- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有82家主力机构披露2025-06-30报告期持股数据，持仓量总计9879.61万股，占流通A股34.06%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了57%的股票
技术面评分前10的股票
近期的平均成本为8.14元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为8.14元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.14","date":1765094794,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.12.08","stock":"-0.98","trade":null,"ind":"1.39"},{"date":"2025.12.05","stock":"1.24","trade":null,"ind":"1.08"},{"date":"2025.12.04","stock":"-1.71","trade":null,"ind":"0.40"},{"date":"2025.12.03","stock":"0.86","trade":null,"ind":"-0.78"},{"date":"2025.12.02","stock":"0.12","trade":null,"ind":"-0.68"},{"date":"2025.12.01","stock":"0.62","trade":null,"ind":"1.25"},{"date":"2025.11.28","stock":"1.13","trade":null,"ind":"0.85"},{"date":"2025.11.27","stock":"1.27","trade":null,"ind":"-0.25"},{"date":"2025.11.26","stock":"-2.71","trade":null,"ind":"1.02"},{"date":"2025.11.25","stock":"2.53","trade":null,"ind":"1.53"},{"date":"2025.11.24","stock":"3.40","trade":null,"ind":"0.37"},{"date":"2025.11.21","stock":"-6.25","trade":null,"ind":"-3.41"},{"date":"2025.11.20","stock":"-0.97","trade":null,"ind":"-0.76"},{"date":"2025.11.19","stock":"-1.55","trade":null,"ind":"-0.00"},{"date":"2025.11.18","stock":"-1.41","trade":null,"ind":"-0.92"},{"date":"2025.11.17","stock":"0.00","trade":null,"ind":"-0.11"},{"date":"2025.11.14","stock":"1.68","trade":null,"ind":"-1.93"},{"date":"2025.11.13","stock":"0.72","trade":null,"ind":"1.78"},{"date":"2025.11.12","stock":"0.12","trade":null,"ind":"-0.36"},{"date":"2025.11.11","stock":"1.22","trade":null,"ind":"-1.03"},{"date":"2025.11.10","stock":"-0.24","trade":null,"ind":"0.18"}]
黄山胶囊,深证成指,医疗器械指数
压力支撑
该股压力位为8.14元，支撑位为8.04元。
[{"text":"\u538b\u529b\u4f4d","value":"8.14","date":1765123200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.04","date":1765123200,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.8资金面打败了71%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月08日 20:30
| 机构今日流向(万元) | -599.84 | 机构5日流向(万元) | -2009.59 |
| 机构10日流向(万元) | -3866.51 | 机构20日流向(万元) | -11054.06 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加694.04万股，其中基金净增仓1家，主力净增仓54家，有一定的中长期投资价值。
截止2025-06-30，共82家主力机构（基金80家，一般法人1家，QFII1家），持仓量总计9879.61万股，占流通A股34.06%
其中，基金持仓与2024-12-31相比：
增仓：8家 ，增持 197.84万股
减仓：7家 ，减持 20.17万股
新出现在主力名单中：65家 ，持有538.53万股
从主力名单中消失：11家 ，原持有22.16万股
其中，基金持仓与2024-12-31相比：
增仓：8家 ，增持 197.84万股
减仓：7家 ，减持 20.17万股
新出现在主力名单中：65家 ，持有538.53万股
从主力名单中消失：11家 ，原持有22.16万股
消息面诊股
诊断结果：5.8消息面打败了23%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 黄山胶囊：董事会换届选举
2025-11-28 - 黄山胶囊：截至2025年9月30日公司股东总数为1
2025-11-19 - 黄山胶囊前三季度营业收入3.44亿元，同比下降0.
2025-11-03 - 财报速递：黄山胶囊2025年前三季度净利润4906
2025-11-02 - 股东追踪|应小平等新进黄山胶囊前十大流通股东
2025-10-31 - 股东追踪|BARCLAYS BANK PLC等新进
2025-08-22 - 黄山胶囊（截止2025年6月30日）股东人数为17
2025-08-22 - 财报速递：黄山胶囊2025年半年度净利润3555.
2025-08-25 - 黄山胶囊半年度营业收入2.44亿元，同比增长3.6
2025-08-22 - 黄山胶囊：2025年上半年净利润同比增长19.78
2025-08-22
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-29 |
| 利好 | 分红转增 | 10派0.33元(含税) | 2025-10-31 |
| 一般消息 | 高管变动 | 委员会更名 | 2025-10-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 高管变动 | 因已届退休年龄 | 2025-04-25 |
| 利好 | 分红转增 | 10派0.38元(含税) | 2025-03-29 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-02-05 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 利好 | 分红转增 | 10派0.27元(含税) | 2024-12-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 0条 | 5条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：0.0行业面打败了0%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.12.08","price":"1.39","value":null},{"date":"2025.12.05","price":"1.08","value":null},{"date":"2025.12.04","price":"0.40","value":null},{"date":"2025.12.03","price":"-0.78","value":null},{"date":"2025.12.02","price":"-0.68","value":null},{"date":"2025.12.01","price":"1.25","value":null},{"date":"2025.11.28","price":"0.85","value":null},{"date":"2025.11.27","price":"-0.25","value":null},{"date":"2025.11.26","price":"1.02","value":null},{"date":"2025.11.25","price":"1.53","value":null},{"date":"2025.11.24","price":"0.37","value":null},{"date":"2025.11.21","price":"-3.41","value":null},{"date":"2025.11.20","price":"-0.76","value":null},{"date":"2025.11.19","price":"-0.00","value":null},{"date":"2025.11.18","price":"-0.92","value":null},{"date":"2025.11.17","price":"-0.11","value":null},{"date":"2025.11.14","price":"-1.93","value":null},{"date":"2025.11.13","price":"1.78","value":null},{"date":"2025.11.12","price":"-0.36","value":null},{"date":"2025.11.11","price":"-1.03","value":null},{"date":"2025.11.10","price":"0.18","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 热景生物 | 25.44% | 3.43% | 5.6分 |
| 2 | 康众医疗 | 19.57% | 10.57% | 5.7分 |
| 3 | 浩欧博 | 15.42% | -2.55% | 6.0分 |
| 4 | 国发股份 | 12.95% | 3.92% | 5.7分 |
| 5 | 中红医疗 | 11.63% | 3.55% | 4.7分 |
| 6 | 华兰股份 | 9.21% | -0.57% | 4.4分 |
| 8 | 中源协和 | 3.92% | -3.03% | 4.8分 |
| 10 | 海利生物 | 2.42% | 4.96% | 5.4分 |
| 12 | 五洲医疗 | 0.99% | 4.44% | 4.9分 |
| 14 | 万东医疗 | 0.82% | -1.42% | 4.8分 |
| 16 | 东星医疗 | 0.26% | 0.41% | 3.9分 |
| 18 | 九强生物 | 0.07% | -1.94% | 4.8分 |
| 20 | 黄山胶囊 | -1.10% | -0.49% | 5.2分 |
| 22 | 大博医疗 | -1.60% | -2.02% | 5.2分 |
| 24 | ST凯利 | -1.90% | -1.39% | 4.5分 |
| 26 | 凯普生物 | -2.17% | -0.34% | 4.1分 |
| 28 | 健尔康 | -2.48% | -2.72% | 4.6分 |
| 30 | 可孚医疗 | -2.69% | 1.34% | 5.9分 |
| 32 | 美好医疗 | -2.81% | 0.00% | 4.7分 |
| 34 | 威高骨科 | -2.95% | -1.13% | 4.8分 |
| 36 | 东方海洋 | -3.04% | -0.39% | 4.4分 |
| 38 | 尚荣医疗 | -3.21% | -0.76% | 5.1分 |
| 40 | 南卫股份 | -3.24% | 2.69% | 4.7分 |
| 42 | 天臣医疗 | -3.53% | 3.27% | 5.5分 |
| 44 | 健帆生物 | -3.64% | -0.94% | 4.3分 |
| 46 | 南微医学 | -3.73% | 0.26% | 5.8分 |
| 48 | 安旭生物 | -3.78% | -1.61% | 4.8分 |
| 50 | 维力医疗 | -3.86% | -0.44% | 5.6分 |
| 52 | 阳普医疗 | -4.02% | -2.48% | 4.6分 |
| 54 | 安杰思 | -4.14% | -0.49% | 5.1分 |
| 56 | 达安基因 | -4.32% | -2.58% | 3.9分 |
| 58 | 明德生物 | -4.42% | -2.13% | 3.2分 |
| 60 | 迈克生物 | -4.58% | -0.78% | 4.0分 |
| 62 | 康拓医疗 | -4.66% | -0.03% | 5.9分 |
| 64 | 蓝帆医疗 | -5.05% | -4.22% | 3.7分 |
| 66 | 威高血净 | -5.19% | 0.58% | 5.7分 |
| 68 | 亚辉龙 | -5.39% | -2.64% | 4.5分 |
| 70 | 英诺特 | -5.62% | -4.40% | 4.1分 |
| 72 | 之江生物 | -5.70% | -2.98% | 3.7分 |
| 74 | 爱博医疗 | -6.01% | -0.18% | 4.9分 |
| 76 | 睿昂基因 | -6.28% | 0.07% | 5.2分 |
| 78 | 伟思医疗 | -6.38% | -0.28% | 5.5分 |
| 80 | 爱朋医疗 | -6.49% | -0.26% | 4.4分 |
| 82 | 戴维医疗 | -6.56% | -3.35% | 4.2分 |
| 84 | 奥泰生物 | -6.84% | -2.34% | 4.3分 |
| 86 | 济民健康 | -7.02% | -4.08% | 3.5分 |
| 88 | 东方生物 | -7.09% | -3.94% | 3.8分 |
| 90 | 麦澜德 | -7.17% | -5.71% | 5.2分 |
| 92 | 西山科技 | -7.34% | -2.28% | 4.2分 |
| 94 | 福瑞股份 | -7.50% | 1.97% | 5.7分 |
| 96 | 易瑞生物 | -7.64% | -2.65% | 4.3分 |
| 98 | 澳华内镜 | -7.67% | -0.70% | 4.6分 |
| 100 | 九安医疗 | -8.03% | -2.02% | 4.0分 |
| 102 | 海尔生物 | -8.04% | -1.14% | 4.9分 |
| 104 | 安图生物 | -8.07% | -1.48% | 4.6分 |
| 106 | 仁度生物 | -8.91% | -1.63% | 5.3分 |
| 108 | 安必平 | -9.32% | -3.86% | 3.8分 |
| 110 | 超研股份 | -9.71% | -2.69% | 5.2分 |
| 112 | 冠昊生物 | -10.09% | -4.13% | 4.2分 |
| 114 | 圣湘生物 | -10.29% | -3.00% | 4.6分 |
| 116 | 奥精医疗 | -10.69% | -1.65% | 4.0分 |
| 118 | 奥美医疗 | -11.04% | -1.55% | 4.9分 |
| 120 | 硕世生物 | -12.18% | 1.24% | 5.4分 |
| 122 | 康为世纪 | -12.76% | -5.61% | 3.7分 |
| 124 | 春立医疗 | -13.21% | -0.90% | 5.2分 |
| 126 | 采纳股份 | -13.87% | 1.63% | 4.0分 |
| 128 | - | -15.20% | -3.00% | 分 |
| 130 | 惠泰医疗 | -15.29% | -0.01% | 5.4分 |
| 132 | 楚天科技 | -16.32% | -1.38% | 4.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 54/245 ， 110/245。
[{"date":"2025-09-30","value":"5.25","vol":"2.86"},{"date":"2025-06-30","value":"3.83","vol":"2.27"},{"date":"2025-03-31","value":"2.03","vol":"1.15"},{"date":"2024-12-31","value":"5.42","vol":"0.53"},{"date":"2024-09-30","value":"4.47","vol":"4.71"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.25 | 3.83 | 2.03 | 5.42 | 4.47 |
| 行业(%) | 2.86 | 2.27 | 1.15 | 0.53 | 4.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"29.32","vol":"51.79"},{"date":"2025-06-30","value":"28.98","vol":"52.10"},{"date":"2025-03-31","value":"29.26","vol":"51.81"},{"date":"2024-12-31","value":"25.52","vol":"52.63"},{"date":"2024-09-30","value":"25.62","vol":"53.49"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.32 | 28.98 | 29.26 | 25.52 | 25.62 |
| 行业(%) | 51.79 | 52.10 | 51.81 | 52.63 | 53.49 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/245 ， 32/245。
[{"date":"2025-09-30","value":"-0.69","vol":"-0.61"},{"date":"2025-06-30","value":"3.66","vol":"-1.71"},{"date":"2025-03-31","value":"0.53","vol":"-0.92"},{"date":"2024-12-31","value":"2.31","vol":"0.64"},{"date":"2024-09-30","value":"-2.54","vol":"0.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.69 | 3.66 | 0.53 | 2.31 | -2.54 |
| 行业(%) | -0.61 | -1.71 | -0.92 | 0.64 | 0.79 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"21.01","vol":"-18.69"},{"date":"2025-06-30","value":"19.78","vol":"-20.27"},{"date":"2025-03-31","value":"22.90","vol":"-4.25"},{"date":"2024-12-31","value":"-24.07","vol":"-24.11"},{"date":"2024-09-30","value":"-26.43","vol":"-20.23"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
21.01 | 19.78 | 22.90 | -24.07 | -26.43 |
| 行业(%) | -18.69 | -20.27 | -4.25 | -24.11 | -20.23 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 36/245 ， 17/245。
[{"date":"2025-09-30","value":"0.31","vol":"0.25"},{"date":"2025-06-30","value":"0.22","vol":"0.17"},{"date":"2025-03-31","value":"0.11","vol":"0.08"},{"date":"2024-12-31","value":"0.43","vol":"0.35"},{"date":"2024-09-30","value":"0.32","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.31 | 0.22 | 0.11 | 0.43 | 0.32 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.35 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.61","vol":"1.67"},{"date":"2025-06-30","value":"1.77","vol":"1.13"},{"date":"2025-03-31","value":"0.84","vol":"0.55"},{"date":"2024-12-31","value":"3.16","vol":"2.33"},{"date":"2024-09-30","value":"2.28","vol":"1.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.61 | 1.77 | 0.84 | 3.16 | 2.28 |
| 行业(次) | 1.67 | 1.13 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"18.38","vol":"14.91"},{"date":"2025-06-30","value":"17.30","vol":"15.06"},{"date":"2025-03-31","value":"6.30","vol":"4.01"},{"date":"2024-12-31","value":"35.31","vol":"29.57"},{"date":"2024-09-30","value":"27.03","vol":"15.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.38 | 17.30 | 6.30 | 35.31 | 27.03 |
| 行业 | 14.91 | 15.06 | 4.01 | 29.57 | 15.40 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.03","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.29","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.03 | - | 0.29 | - |
| 行业 | 0.00 | 1.57 | 0.00 | 2.19 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 50/245 ， 56/245。
[{"date":"2025-09-30","value":"3.55","vol":"5.68"},{"date":"2025-06-30","value":"3.78","vol":"5.50"},{"date":"2025-03-31","value":"3.98","vol":"5.89"},{"date":"2024-12-31","value":"3.92","vol":"5.34"},{"date":"2024-09-30","value":"4.00","vol":"5.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.55 | 3.78 | 3.98 | 3.92 | 4.00 |
| 行业 | 5.68 | 5.50 | 5.89 | 5.34 | 5.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.94","vol":"4.56"},{"date":"2025-06-30","value":"3.14","vol":"4.40"},{"date":"2025-03-31","value":"3.31","vol":"4.77"},{"date":"2024-12-31","value":"3.23","vol":"4.32"},{"date":"2024-09-30","value":"3.20","vol":"4.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.94 | 3.14 | 3.31 | 3.23 | 3.20 |
| 行业 | 4.56 | 4.40 | 4.77 | 4.32 | 4.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 84/245 ， 85/245。
[{"date":"2025-09-30","value":"14.10","vol":"22.06"},{"date":"2025-06-30","value":"15.09","vol":"22.01"},{"date":"2025-03-31","value":"15.09","vol":"21.24"},{"date":"2024-12-31","value":"15.53","vol":"21.92"},{"date":"2024-09-30","value":"13.96","vol":"20.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.10 | 15.09 | 15.09 | 15.53 | 13.96 |
| 行业(%) | 22.06 | 22.01 | 21.24 | 21.92 | 20.92 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.16","vol":"0.72"},{"date":"2025-06-30","value":"0.18","vol":"0.58"},{"date":"2025-03-31","value":"0.18","vol":"0.57"},{"date":"2024-12-31","value":"0.18","vol":"0.55"},{"date":"2024-09-30","value":"0.16","vol":"0.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.16 | 0.18 | 0.18 | 0.18 | 0.16 |
| 行业(%) | 0.72 | 0.58 | 0.57 | 0.55 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.61","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.65","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]